WEBINAR | REMS Technology Innovation: Reducing Pharmacy REMS Stakeholder Burden
REMS programs often require REMS stakeholders (patients, prescribers, and pharmacists) to complete transactions within the REMS implementation system to ensure that REMS activities have been fulfilled before the drug can be prescribed and/or dispensed. This activity is often performed outside of traditional healthcare workflow and systems, and therefore may increase stakeholder burden for participating in REMS programs.
Sponsored by a grant from the NCPDP Foundation, pharmaceutical companies, the Food and Drug Administration (FDA) and REMS industry partners have been focused on addressing REMS stakeholder burden concerns through a variety of IT initiatives.
In this webinar, learn more about this one-of-a-kind initiative to address pharmacy REMS stakeholder burden, that aims to move the industry toward a more integrated, automated and aligned REMS implementation system approach.
Related Content
Looking for exclusive insight?
